Literature DB >> 28339574

Arm Paralysis After Routine Childhood Vaccinations: Application of Advanced Molecular Methods to the Causality Assessment of an Adverse Event After Immunization.

Jana Shaw1, Neal A Halsey2, Adriana Weinberg3, D Scott Schmid4, Kirsten St George5, William C Weldon6, Michael Jordan7, Patrick W Bryant8, Philip S LaRussa9, Deborah Y Bradshaw10, Theresa Harrington11, Anne Gershon12.   

Abstract

Post-licensure surveillance for adverse events following immunizations (AEFI) can identify rare complications of vaccinations and rigorous vaccine adverse event causality assessments can help to identify possible causal relationships. We report the development of arm paralysis after varicella vaccination in a 1-year-old child. Paralysis was initially presumed to be due to vOka because of the temporal relationship between vaccination and onset of arm weakness; however, molecular studies identified wild-type varicella zoster virus VZV (WT-VZV) in the CSF, leading the authors to conclude that WT-VZV was the probable cause. This case illustrates the complexity of assessing AEFI causality, and the importance of careful and complete evaluations when determining the most likely cause of an AEFI.
© The Author 2017. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  adverse event after vaccination; child; paralysis; vaccine; varicella-zoster virus

Mesh:

Year:  2017        PMID: 28339574      PMCID: PMC6251534          DOI: 10.1093/jpids/piw084

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN: 2048-7193            Impact factor:   3.164


  27 in total

1.  Central nervous system complications of varicella-zoster virus.

Authors:  Michelle Science; Daune MacGregor; Susan E Richardson; Sanjay Mahant; Dat Tran; Ari Bitnun
Journal:  J Pediatr       Date:  2014-07-22       Impact factor: 4.406

2.  Molecular analysis of varicella vaccines and varicella-zoster virus from vaccine-related skin lesions.

Authors:  Sonja Thiele; Aljona Borschewski; Judit Küchler; Marc Bieberbach; Sebastian Voigt; Bernhard Ehlers
Journal:  Clin Vaccine Immunol       Date:  2011-05-11

3.  Recombination in tissue culture between varicella-zoster virus strains.

Authors:  D E Dohner; S G Adams; L D Gelb
Journal:  J Med Virol       Date:  1988-03       Impact factor: 2.327

4.  Varicella-zoster virus infection in children with underlying human immunodeficiency virus infection.

Authors:  A A Gershon; N Mervish; P LaRussa; S Steinberg; S H Lo; D Hodes; S Fikrig; V Bonagura; S Bakshi
Journal:  J Infect Dis       Date:  1997-12       Impact factor: 5.226

5.  Genotyping of varicella-zoster virus and the discrimination of Oka vaccine strains by TaqMan real-time PCR.

Authors:  S P Parker; M Quinlivan; Y Taha; J Breuer
Journal:  J Clin Microbiol       Date:  2006-11       Impact factor: 5.948

6.  Neutralization of Enterovirus D68 isolated from the 2014 US outbreak by commercial intravenous immune globulin products.

Authors:  Yiting Zhang; Deborah D Moore; W Allan Nix; M Steven Oberste; William C Weldon
Journal:  J Clin Virol       Date:  2015-06-19       Impact factor: 3.168

7.  Varicella vaccination and ischemic stroke in children: is there an association?

Authors:  James G Donahue; Burney A Kieke; W Katherine Yih; Nicholas R Berger; Jeremy S McCauley; James Baggs; Kenneth M Zangwill; Roger Baxter; Eileen M Eriksen; Jason M Glanz; Simon J Hambidge; Nicola P Klein; Edwin M Lewis; S Michael Marcy; Allison L Naleway; James D Nordin; Paula Ray; Edward A Belongia
Journal:  Pediatrics       Date:  2009-02       Impact factor: 7.124

Review 8.  Varicella zoster virus infection.

Authors:  Anne A Gershon; Judith Breuer; Jeffrey I Cohen; Randall J Cohrs; Michael D Gershon; Don Gilden; Charles Grose; Sophie Hambleton; Peter G E Kennedy; Michael N Oxman; Jane F Seward; Koichi Yamanishi
Journal:  Nat Rev Dis Primers       Date:  2015-07-02       Impact factor: 52.329

9.  Acute Flaccid Myelitis in the United States, August-December 2014: Results of Nationwide Surveillance.

Authors:  James J Sejvar; Adriana S Lopez; Margaret M Cortese; Eyal Leshem; Daniel M Pastula; Lisa Miller; Carol Glaser; Anita Kambhampati; Kayoko Shioda; Negar Aliabadi; Marc Fischer; Nicole Gregoricus; Robert Lanciotti; W Allan Nix; Senthilkumar K Sakthivel; D Scott Schmid; Jane F Seward; Suxiang Tong; M Steven Oberste; Mark Pallansch; Daniel Feikin
Journal:  Clin Infect Dis       Date:  2016-06-17       Impact factor: 9.079

10.  Enterovirus D68 Infection in Children with Acute Flaccid Myelitis, Colorado, USA, 2014.

Authors:  Negar Aliabadi; Kevin Messacar; Daniel M Pastula; Christine C Robinson; Eyal Leshem; James J Sejvar; W Allan Nix; M Steven Oberste; Daniel R Feikin; Samuel R Dominguez
Journal:  Emerg Infect Dis       Date:  2016-08       Impact factor: 6.883

View more
  2 in total

Review 1.  Varicella Virus Vaccination in the United States.

Authors:  Jana Shaw; Anne A Gershon
Journal:  Viral Immunol       Date:  2017-11-27       Impact factor: 2.257

2.  Vaccine Strain and Wild-Type Clades of Varicella-Zoster Virus in Central Nervous System and Non-CNS Disease, New York State, 2004-2019.

Authors:  Patrick Bryant; Tugba Yildirim; Sara B Griesemer; Kara Shaw; Dylan Ehrbar; Kirsten St George
Journal:  J Clin Microbiol       Date:  2022-03-24       Impact factor: 11.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.